Real-world evidence on the strategy of olmesartan-based triple single-pill combination in Korean hypertensive patients: a prospective, multicenter, observational study (RESOLVE-PRO)

Table 1 Demographic and baseline characteristics (enrolled set)

Characteristic	Enrolled set (n = 3752)
Age (yr)	62.7 ± 13.3
Age group (yr)
< 60	1395 (37.2)
60–64	458 (12.2)
65–69	552 (14.7)
70–74	548 (14.6)
75–80	499 (13.3)
> 80	247 (6.6)
Elderly age (≥65 yr)	1846 (49.2)
Sex
Male	2145 (57.2)
Female	1554 (41.4)
Baseline height (cm), n = 2917	163.0 ± 9.3
Baseline body weight (kg), n = 2931	70.1 ± 14.0
BMI (kg/m²), n = 2877	26.1 ± 4.1
Baseline SBP (mmHg), n = 3640	143.6 ± 19.2
Baseline DBP (mmHg), n = 3638	83.6 ± 14.0
Hypertension period (yr), n = 2603	9.3 ± 8.1
Smoking status, smoker	663 (17.7)
Alcohol consumption, yes	1053 (28.1)
Family history of hypertension, yes	731 (19.5)
Accompanying risk factor, yes	2378 (63.4)
Accompanying risk factor
Renal disease	141 (3.8)
Diabetes	1231 (32.8)
Others	1597 (42.6)

Data are presented as mean ± standard deviation or number (%). Hypertension period (mo) = (enrollment date – date of hypertension diagnosis + 1) / 30.44. The date of hypertension diagnosis was assumed to be the first day of the month in the recorded year. Duplicates were allowed for accompanying risk factors
BMI body mass index, SBP systolic blood pressure, DBP diastolic blood pressure

ISSN: 2056-5909